Pinova

From WikiMD's WELLNESSPEDIA

Pinova (also known as Pinata or Corail apple) is a cultivar of apple (Malus domestica) that was first cultivated in Germany in 1986. It is a cross between the cultivars Golden Delicious and Clivia, and is known for its sweet and slightly tart flavor, as well as its resistance to common apple diseases.

History[edit]

The Pinova apple was first cultivated in 1986 by the Dresden-Pillnitz Fruit Research Station in Germany. It was created as part of a breeding program that aimed to develop new apple cultivars with improved disease resistance and superior fruit quality. The Pinova apple is a cross between the Golden Delicious and Clivia cultivars, combining the sweet flavor of the former with the disease resistance of the latter.

Characteristics[edit]

Pinova apples are medium-sized and have a conical shape. The skin is smooth and has a yellow base color with a red-orange blush. The flesh is firm, crisp, and juicy, with a sweet and slightly tart flavor. The apples ripen in late October and can be stored for several months without losing their quality.

Pinova trees are vigorous and have a spreading growth habit. They are resistant to common apple diseases such as Apple scab and Powdery mildew, making them a popular choice for organic apple production.

Cultivation[edit]

Pinova apples are grown in various parts of the world, including Europe, North America, and New Zealand. They are suitable for growing in USDA hardiness zones 4-8. The trees prefer full sun and well-drained soil. They are partially self-fertile, but cross-pollination with another apple cultivar can increase fruit yield.

Uses[edit]

Pinova apples are versatile and can be used for fresh eating, cooking, and baking. They are also used in cider production due to their balanced flavor profile.

See also[edit]


This article is a stub related to food. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.